GlassScriptPhysician profile
Kevin James Stepp
NPI 1356476303
$10,305.77
in general payments reported to CMS, 2019-2025
9 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,849 · 2020: $46.82 · 2021: $247 · 2022: $80.15 · 2023: $814 · 2024: $7,116 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $1,283 · Travel and Lodging: $778 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $1,282.69 |
| Travel and Lodging | $777.99 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Distalmotion US | $6,639.00 | 2024 | Dexter L6 Robot |
| Intuitive Surgical, INC. | $2,141.52 | 2019-2024 | Da Vinci Surgical System |
| Coloplast Corp | $951.54 | 2019-2025 | Saffron |
| Coopersurgical, INC. | $206.52 | 2019 | |
| Boston Scientific Corporation | $180.18 | 2024-2025 | Solyx Sis System, General - Ep |
| Abbvie INC. | $125.00 | 2019 | |
| Femselect INC. | $25.00 | 2024 | Enplace |
| Ethicon US, LLC | $18.70 | 2020 | |
| Masimo Corporation | $18.31 | 2025 | Sedline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Stepp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.